Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Masayuki Kazahaya (NPI 1619974391)

Field	Value
Entity Type	Individual
Organization	Masayuki Kazahaya
Address	1251 S Cedar Crest Blvd
City	Allentown
State	PA
ZIP	18103
Taxonomy	Ophthalmology Physician
NPI Enumerated	July 7, 2005

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider is functionally a high-volume ophthalmic injector and retinal care specialist based on Medicare billing: J0178 (aflibercept) accounts for $2.3M of Medicare revenue (63.1% of the provider's total Medicare revenue) and J2777 (faricimab) accounts for $501.6K (13.5%). The prominence of these intravitreal drug codes, together with the vitreous injection code 67028 ($211.2K, 5.7%), indicates clinical activity focused on intravitreal pharmacotherapy for retinal disease rather than primarily refractive or low-acuity office care.

Revenue is highly concentrated in a small set of services: the precomputed top 3 Medicare codes account for 82.3% of this provider’s total Medicare revenue. That concentration signals dependence on anti-VEGF/related intravitreal therapies for the bulk of earnings, which is an important commercial risk and negotiating consideration for payers and partners.

The provider’s Medicare scale is meaningful and effectively single-payer from a public program perspective: lifetime Medicare revenue is $3.7M while there is no Medicaid billing on file. Analysts should treat this practice as Medicare-dominant for public-payer contracting and utilization benchmarking, since there is no recorded Medicaid activity to balance payer mix.

Competitive standing on key codes is above typical national volume: J0178 ranks #119 of 3204 providers nationally (96th percentile; notably above typical national volume) and 67028 ranks #236 of 4255 (94th percentile; notably above typical national volume). For imaging and exam services, the provider is an extreme outlier—92014 ranks #216 of 35415 providers (99th percentile; extreme outlier) and 92134 ranks #68 of 26868 providers (100th percentile; extreme outlier)—which together indicate unusually high patient visit and retinal imaging throughput relative to peers.

Service mix includes high diagnostic imaging and comprehensive exams alongside injections: 92014 generated $173.2K (4.7% of Medicare revenue) and 92134 generated $130.7K (3.5%), reflecting a workflow that pairs frequent office encounters and retinal imaging with intravitreal therapy. This combination is consistent with a practice that manages chronic retinal conditions requiring serial injections and interval imaging follow-up.

Although the practice is injection- and clinic-focused, there is evidence of some surgical capability at low volume: 67042 shows 23 claims for $20.2K (0.5% of Medicare revenue) and other procedure codes (e.g., 67210, 67145) appear at modest levels. This suggests the provider may handle occasional surgical retinal procedures in addition to predominant medical retina services rather than running a high-volume surgical retina center.

Tenure and stability: the NPI was enumerated 2005-07-07 (~21 years ago), indicating long-standing Medicare participation. That longevity, combined with the high percentile ranks on core codes, supports characterization of this clinician as an established regional retinal care provider rather than a newly entered practice.

Several codes are statistically notable by the dataset’s labels and should guide peer-comparisons: the provider is labeled an extreme outlier on 92014 and 92134 and is notably above typical national volume on J0178 and 67028. These labeled outlier statuses point to very high visit, imaging, and intravitreal injection volumes that payers and provider partners should prioritize for utilization review, capacity planning, and network contracting discussions.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,400	$690	$2.3M
J2777	Injection, faricimab‑svoa, 0.1 mg	17,300	$30	$501.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,350	$90	$211.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,090	$80	$173.2K
J2778	Injection, ranibizumab, 0.1 mg	770	$180	$138.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,670	$30	$130.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	690	$60	$43.2K
J7999	Compounded drug, not otherwise classified	640	$70	$41.5K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	220	$160	$34.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	320	$90	$28.9K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Masayuki Kazahaya — 4 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	12	140	830	$690	$865.1K
J2778	42	70	1,030	$190	$417.1K
J2777	23	100	7,950	$30	$360.2K
67028	20	180	600	$90	$87.5K
J7312	11	10	280	$160	$50.7K
J7999	4	110	100	$120	$33.3K
67042	20	50	20	$1,100	$31.9K
92014	7	1,570	130	$80	$21K
67210	10	30	30	$370	$16K
99214	3,846	23,230	100	$80	$14.5K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Masayuki Kazahaya, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bozho Todorich	PA	Retina Specialist (Ophthalmology) Physician	$788.3K	$6.3K
David De Rose	PA	Ophthalmology Physician	$715.7K	$0
Julie Mclaughlin	PA	Optometrist	$282.9K	$0
Tricia Lennox Thomas	PA	Ophthalmology Physician	$235.4K	$0

Nearby Providers

Other providers in the same ZIP code as Masayuki Kazahaya, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Lehigh Valley Hospital	PA	General Acute Care Hospital	$0	$64.3M
Lehigh Valley Physician Group	PA	Emergency Medicine Physician	$0	$16.3M
Preferred Home Health Care & Nursing Services Inc.	PA	Home Health Agency	$0	$12.1M
Lehigh Valley Hospital	PA	Children's Hospital	$0	$10M
Efcc Acquisition Corp	PA	Home Health Agency	$0	$9.6M
Medical Imaging Of Lehigh Valley PC	PA	Diagnostic Radiology Physician	$0	$9.5M
Lehigh Valley Physician Group	PA	Pediatric Emergency Medicine (Emergency Medicine) Physician	$0	$5.9M
Ya-yu Lee	PA	Endocrinology, Diabetes & Metabolism Physician	$831K	$0
Neil Feldman	PA	Allergy Physician	$808K	$1.6K
Susan Kim	PA	Rheumatology Physician	$770.1K	$0

Masayuki Kazahaya — Billing Profile & Reimbursement Data

Sign up for Masayuki Kazahaya — Billing Profile & Reimbursement Data policy alerts

Masayuki Kazahaya — Billing Profile & Reimbursement Data

Sign up for Masayuki Kazahaya — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References